Voss Value-Oriented Special Situations Fund, LP

10% OwnerRein Therapeutics, Inc. (RNTX) · full profile →Form 4 · filed Oct 28, 2025
Net Buying
Open-Market Buys
$423K
Open-Market Sells
$0
Net Open-Market Flow
$423K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2025Buy(P)178K$1.39$248K500K
Oct 27, 2025Buy(P)93K$1.37$127K822K
Oct 27, 2025Buy(P)5K$1.37$7K322K
Oct 24, 2025Buy(P)30K$1.39$42K730K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000921895-25-002819) within minutes of acceptance. Every field above traces to the original document. Verify it directly: